Design, synthesis, and pharmacological evaluation of novel tetrahydroprotoberberine derivatives: Selective inhibitors of dopamine D 1 receptor
…, Z Li, L Zhu, R Zhao, L Zhang, S Zhou, Y Zhou…
Index: Qian, Wangke; Lu, Weijian; Sun, Haifeng; Li, Zeng; Zhu, Liyuan; Zhao, Rui; Zhang, Lei; Zhou, Shengbin; Zhou, Yu; Jiang, Hualiang; Zhen, Xuechu; Liu, Hong Bioorganic and Medicinal Chemistry, 2012 , vol. 20, # 15 p. 4862 - 4871
Full Text: HTML
Citation Number: 12
Abstract
A series of new tetrahydroprotoberberine (THPB) derivatives were designed, synthesized, and tested for their binding affinity towards dopamine (D1 and D2) and serotonin (5-HT1A and 5-HT2A) receptors. Many of the THPB compounds exhibited high binding affinity and activity at the dopamine D1 receptor, as well as high selectivity for the D1 receptor over the D2, 5-HT1A, and 5-HT2A receptors. Among these, compound 19c exhibited a promising ...
Related Articles:
2, 3, 9-and 2, 3, 11-Trisubstituted tetrahydroprotoberberines as D 2 dopaminergic ligands
[Parraga, Javier; Cabedo, Nuria; Andujar, Sebastian; Piqueras, Laura; Moreno, Laura; Galan, Abraham; Angelina, Emilio; Enriz, Ricardo D.; Ivorra, Maria Dolores; Sanz, Maria Jesus; Cortes, Diego European Journal of Medicinal Chemistry, 2013 , vol. 68, p. 150 - 166]
Antiplatelet activity of synthetic pyrrolo-benzylisoquinolines
[Kuo, Reen-Yen; Wu, Chin-Chung; Chang, Fang-Rong; Yeh, Jwu-Lai; Chen, Ing-Jun; Wu, Yang-Chang Bioorganic and Medicinal Chemistry Letters, 2003 , vol. 13, # 5 p. 821 - 823]